The additive effects of hepatitis C infection and end-stage renal disease in porphyria cutanea tarda.
Various factors contribute to the development of porphyria cutanea tarda (PCT). In this case report, we describe a patient with hepatitis C infection and chronic renal failure. The individual mechanisms, which promote cutaneous disease, are discussed. Finally, we propose that each factor may have an additive effect in prolonging the skin lesions of PCT.
Chan
Owen T M
OT
University of Hawaii, Honolulu, HI, USA.
Tsai
Naoky
N
Wong
Ramona L
RL
Izumi
Allan K
AK
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002506:Cephalexin / Q000627:therapeutic use; D019698:Hepatitis C, Chronic / Q000150:complications*; D006801:Humans; D019190:Iron Overload / Q000150:complications / Q000209:etiology / Q000517:prevention & control; D007676:Kidney Failure, Chronic / Q000150:complications*; D008297:Male; D008875:Middle Aged; D018962:Phlebotomy; D017119:Porphyria Cutanea Tarda / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D014578:Uroporphyrins / Q000009:adverse effects*
D000900:Anti-Bacterial Agents; D014578:Uroporphyrins; D002506:Cephalexin